Keyphrases
Risk Factors
100%
Metabolic
100%
Clinical High Risk
100%
Left Ventricular Hypertrophy
100%
Hypertensive Patients
100%
Left Ventricular Mass
100%
Patient Identification
100%
Aldosterone
35%
Endothelin-1 (ET-1)
28%
Posterior Wall Thickness
21%
Hypertensive Subjects
21%
Significant Predictors
14%
C-reactive Protein
14%
Homocysteine
14%
Oxidative Stress
7%
Hemoglobin A1c (HbA1c)
7%
Treatment Strategy
7%
Insulin Resistance
7%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
7%
Inverse Association
7%
High-density Lipoprotein Cholesterol (HDL-C)
7%
High-risk Subjects
7%
Serum Lipids
7%
Inflammation Markers
7%
Multiple Linear Regression Analysis
7%
Lipids
7%
Heart Failure
7%
Cardiovascular Morbidity
7%
Cardiovascular Mortality
7%
Renin
7%
Vascular Endothelial Function
7%
Microalbuminuria
7%
Mass Wall
7%
Neurohormonal
7%
Interventricular Septal Thickness
7%
Screening Strategy
7%
Glomerular Function
7%
Insulin Homeostasis
7%
Formulation Screening
7%
Medicine and Dentistry
Left Ventricular Hypertrophy
100%
Aldosterone
83%
Endothelin
66%
C Reactive Protein
33%
Homocysteine
33%
Oxidative Stress
16%
Urinary System
16%
Cardiovascular System
16%
Insulin Resistance
16%
High Density Lipoprotein Cholesterol
16%
Homeostatic Model Assessment
16%
Multiple Linear Regression Analysis
16%
Congestive Heart Failure
16%
Interventricular Septum
16%
Endothelial Function
16%
Renin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Left Ventricle Hypertrophy
100%
Aldosterone
83%
Endothelin
66%
Insulin Resistance
33%
C Reactive Protein
33%
Homocysteine
33%
High Density Lipoprotein Cholesterol
16%
Inflammation
16%
Congestive Heart Failure
16%
Moroxydine
16%
Renin
16%
Biochemistry, Genetics and Molecular Biology
Heart Left Ventricle Mass
100%
Endothelin
28%
Aldosterone
21%
Insulin Resistance
14%
C-Reactive Protein
14%
Homocysteine
14%
Aldosterone Blood Level
14%
Blood Lipids
7%
Homeostasis
7%
HDL-Cholesterol
7%
Oxidative Stress
7%
Lipid
7%
Serum Lipids
7%
Renin
7%